Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Insulin Resistance 1

Interventions

Metformin 91 Clomiphene 31 Letrozole 23 Inositol 19 Folic Acid 11 Chorionic Gonadotropin 11 Exercise 10 High-Intensity Interval Training 9 drospirenone and ethinyl estradiol combination 8 Ethinyl Estradiol 8 Contraceptives, Oral 8 Cholecalciferol 8 cetrorelix 7 Tablets 7 Progesterone 7 Menotropins 6 follitropin alfa 5 Pioglitazone 5 Liraglutide 5 Exenatide 5 Cyproterone Acetate 5 Caloric Restriction 5 Vitamin D 4 Triptorelin Pamoate 4 Surveys and Questionnaires 4 Sugars 4 Spironolactone 4 Glycoprotein Hormones, alpha Subunit 4 Fish Oils 4 Estradiol 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Polycystic Ovary Syndrome × Canagliflozin × Clear all

NCT04700839 2022-09-10

PCOS

Shanghai 10th People's Hospital

Phase 4 Completed

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡